Skip to main content
    X

    XORTX Therapeutics Inc (XRTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.04
    -0.06 (-5.45%)

    Market Cap: $2.00M

    Last updated: Nov 17, 2026 at 11:00 AM ET

    XORTX Therapeutics Inc (XRTX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to XORTX Therapeutics are Genprex (GNPX), Onconetix (ONCO) and BioRestorative Therapies (BRTX). By market cap, XORTX Therapeutics ranks 9th of the 13 companies on this page; XTL Biopharmaceuticals Ltd ADR (XTLB) is the largest at $3.93M.

    Peer Comparison

    XRTX's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    XORTX Therapeutics (XRTX)$2.00MN/AN/A0.0%N/A0.0%0.00%
    Genprex Inc (GNPX)$1.71MN/AN/A0.0%N/A0.0%0.00%
    Onconetix Inc (ONCO)$2.15MN/A1.0x0.0%N/A-83.9%0.00%
    BioRestorative Therapies Inc (BRTX)$2.06MN/A70.3x0.0%-289.9%-7.3%0.00%
    XTL Biopharmaceuticals Ltd ADR (XTLB)$3.93MN/A4.0x0.0%N/A0.0%0.00%
    Enlivex Therapeutics Ltd (ENLV)$1.82MN/AN/A0.0%-0.3%0.0%0.00%
    Kairos Pharma, Ltd. (KAPA)$1.54MN/AN/A0.0%N/A0.0%0.00%
    Revelation Biosciences Inc (REVB)$2.43MN/AN/A0.0%N/A0.0%0.00%
    Xenetic Biosciences Inc (XBIO)$3.89MN/A1.2x-75.9%N/A12.0%0.00%
    Dermata Therapeutics Inc (DRMA)$3.06MN/A41.3x0.0%N/A0.0%0.00%
    Silexion Therapeutics Corp (SLXN)$1.29MN/A5.9x0.0%N/A0.0%0.00%
    Ernexa Therapeutics Inc. (ERNA)$2.84MN/AN/A0.0%N/A-94.1%0.00%
    Neurosense Therapeutics Ltd (NRSN)$3.21MN/AN/A0.0%N/A0.0%0.00%
    Peer median$2.29MN/A4.9x0.0%-145.1%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to XORTX Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Genprex Inc (GNPX)
    Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes.
    GNPX competitors
    Onconetix Inc (ONCO)
    Onconetix Inc. is a cutting-edge biotechnology firm committed to revolutionizing cancer care with its innovative diagnostic and therapeutic solutions.
    ONCO competitors
    BioRestorative Therapies Inc (BRTX)
    BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue...
    BRTX competitors
    XTL Biopharmaceuticals Ltd ADR (XTLB)
    XTL Biopharmaceuticals Ltd., a biopharmaceutical company, is engaged in the acquisition and development of pharmaceutical products for the treatment...
    Enlivex Therapeutics Ltd (ENLV)
    Enlivex Therapeutics Ltd. is a clinical stage immunotherapy company. The company is headquartered in Nes Ziona, Israel.
    ENLV competitors
    Kairos Pharma, Ltd. (KAPA)
    Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients.
    KAPA competitors
    Revelation Biosciences Inc (REVB)
    Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics...
    REVB competitors
    Xenetic Biosciences Inc (XBIO)
    Xenetic Biosciences, Inc., a biopharmaceutical company, is focused on advancing XCART...
    XBIO competitors
    Dermata Therapeutics Inc (DRMA)
    Dermata Therapeutics Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for dermatological conditions...
    DRMA competitors
    Silexion Therapeutics Corp (SLXN)
    Biomotion Sciences (SLXN) is a forward-thinking biotechnology firm specializing in regenerative medicine...
    SLXN competitors
    Ernexa Therapeutics Inc. (ERNA)
    Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients.
    ERNA competitors
    Neurosense Therapeutics Ltd (NRSN)
    Neurosense Therapeutics Ltd (NRSN) is a clinical-stage biotechnology firm dedicated to innovating treatments for neurodegenerative diseases...

    Frequently Asked Questions About XRTX

    Who are XORTX Therapeutics' main competitors?

    The companies most similar to XORTX Therapeutics include Genprex (GNPX), Onconetix (ONCO), BioRestorative Therapies (BRTX), XTL Biopharmaceuticals Ltd ADR (XTLB) and Enlivex Therapeutics (ENLV), listed from the closest match.

    Who is XORTX Therapeutics' biggest competitor?

    XTL Biopharmaceuticals Ltd ADR (XTLB) is the largest of the similar companies at $3.93M; Genprex (GNPX) is the closest match by business profile, size, sector and industry.

    How does XRTX stock compare with its competitors?

    XRTX's net margin is 0.0% against a peer median of 0.0%.

    Which of XORTX Therapeutics' competitors pays a higher dividend?

    XORTX Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is XORTX Therapeutics bigger than its competitors?

    No. XORTX Therapeutics is 9th by market cap among the 13 companies on this page; the largest is XTL Biopharmaceuticals Ltd ADR (XTLB) at $3.93M.